C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2484000
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
La présente invention concerne des anticorps monoclonaux neutralisants entièrement humains dirigés contre le récepteur humain du facteur de croissance de type insuline I (IGFR1). Ces anticorps sont utiles pour traiter ou prévenir un cancer chez un sujet. L'invention concerne également des méthodes d'utilisation et de production de ces anticorps.
Brams Peter
Feingersh Mary Diane
Greenberg Robert
Hailey Judith
Pachter Jonathan A.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Neutralizing human anti-igfr antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutralizing human anti-igfr antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing human anti-igfr antibody will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1807502